A few other states are planning or considering obesity drug restrictions in state fiscal year 2026 or 2027, and state interest in expanding coverage of obesity drugs is also waning according to this years survey, with states continuing to report cost as the key factor contributing to obesity drug coverage decisions
Theres no denying that this drug class can lead to significant health benefits, particularly for those with type 2 diabetes and/or obesity
Phentermine, which aids appetite suppression
Transient and mostly mild-to-moderate gastrointestinal symptoms were the most frequently reported AE and occurred more frequently with the 4 mg starting dose groups rather than the 2 mg starting dose groups [67]
Nausea is the most commonly reported side effect of GLP-1s used for weight loss
Fish Shellfish Immunol (2007) 22(3):25263.10.1016/j.fsi.2006.05.006 149 WangHSteedsJMotomuraYDengYVerma-GandhuMEl-SharkawyRTet alCD4+ T cell-mediated immunological control of enterochromaffin cell hyperplasia and 5-hydroxytryptamine production in enteric infection